seema mody. the next guest is on a hunt for opportunities. let's hit options action and get the trade with brian stutland. brian? >> on the hunt is right. a name that's interesting to me is stone energy. a home-grown american company looking at exploration of getting gas and oil right here in the united states, in the appalachian region, in the gulf of mexico. the stock had a tremendous run in 2011, up 17% or so. 2012 has already been a great year for the stock. i think there's more room to run for here. valuations are still compelling, and with earnings next week, i want to echo a bullish sentiment in the options market. by march, a call. i'll sell a march 32 put against that. net net, the trade only cost a dime here. what i do is allocate cash in case i have to buy the stock below 32. i have all the upside potential above 36. if the earnings come out great, i have the upside, if you look at a one-year chart, it could make a new high on its earnings play. it looks very compelling. this is brian stutland bringing you your energy play and earn

acquisition on the call, some saying there will be more details on the action coming up soon. >> seema mody with the latest there. super bowl xlvi, up next we speak to the chairman of one of the two teams set to take the field. new york giants chief with us next. >>> super bowl xlvi kicks off sunday on nbc. as the new york giants take on the new england patriots, a rematch from the big game four years ago. throughout the day on cnbc, we've pitted new york against boston in the super bowl cities to see which metro area is better for business. the giants and patriots have won three super bowls in their history, so how have the markets performed on the monday following the wins? and who should call wall street -- who should wall street be cheering for? mary thompson is in foxboro, massachusetts. brian shactman at the met life stadium in new jersey. we start with mary. >> maria, wall street should want the patriots, because quite frankly, they're the better team. as for boston, it has advantages over new york. lower unemployment, lower taxes, high-tech and biotech companies returned double-digi

seema mody will have more on that in just a minute. really exciting news. also sears is moving higher as well. they posted a big loss, but they're selling assets to boost liquidity. a bit of restructuring going on there. more on that one as well. and here behind me is metro pcs. those earnings sharply higher beating estimates and once again investors pushing that stock up by 12%. on the downside safeway down big. down by -- not very safe at all then, is it? down by 7.5% now. q-4 earnings fell. higher costs driving down margins. we saw that story earlier this week with walmart as well. and hewlett packard also sinking down 5% after a 44% drop in q-1 earnings that came out late yesterday following a disappointing report from dell. remember the day before. and kohl's here behind me another retailer getting hit on dropping q-4 earnings. the outlook for q-1 also short of expectations. it's off by merely 5%. let's get to the trading floors. bob, did i leave anything for you to talk about town there at the nyse? >> there's always stuff to talk about, mandy. two to

seema mody with the details. seema? >> maria, that's right. a couple stocks on the move.orth taking a look at. let's start with gentex. shares, a company which makes such equipment is down 13%, more than 13% actually. switch over to scientific games. maker of instant lottery tickets posted a surprising loss due to higher expenses. the stock down around 14%. lastly, biotech firm viva, up another 5%. up 5.8% behind their obesity drug. perhaps receiving fda approval which could be a major milestone in the weight loss market. since winning the backing on thursday, the stock has climbed 113%. can you believe it? back to sglu seema, thank you. big moves there. we take a short break. we've got the closing countdown right after this break. after the bell we'll get the global sector, and monetary policy in two exclusive interviews. barclays bob diamond is with us, as well as charles plosser. both joining me in the next hour of the "closing bell." first, take a look at the averages as we approach the final few minutes of trading for the day. we're back in a moment on "closing bell.

. >> i'm seema mody reporting live from the pharma conference. coming up, we'll take a deep dive into the generic drug market, who the winners and losers are, and how investors are trading the space. here's another question. will the usda guidelines slow it down. here's highlights from our guests on cnbc today. >> it's become clear that hiring has declined. the real question is what it means for the apparels, how quickly will hiring pick up. >> this time of the year, over the past ten years we've seen an uptick in prices as the market switches from winter grade gasoline to summer grade gasoline. cleaner burning gasoline is better for the environment, costs more to produce. at the same time consumption and demand increases as the days get longer. >> in the euro, you haven't seen anyone trying to weaken the euro. i think they're happy to see it go lower if it does. i think it helps the situation over there. and desperately in need of some help. >> romney needs to win michigan, period. this is a neck-and-neck race. i think he's going to throw everyt

let's check out now with seema mody what is happening at the nasdaq. and what else also is making headlines today. seema. >> thanks, mandy. here's what else we're watching at this hour. the transportation department delayed a rule that would have rear cameras on cars and trucks. and james murdoch has stepped down as executive chairman as news corp.'s news international unit. rupert murdoch's son will keep his job as news corp.'s deputy chief operating officer. and general motors take a 7% stake in peugot. the two hope various energies will eventually save them $2 billion a year. back to you. >> thank you very much for that, seema mody. flat screens and flat soda. herb's double disaster time. herb. >> mandy, standing here i feel like i should be demonstrating a sodastream machine, not actually talking about their earnings. >> oh, that was famous, wasn't it? or maybe infamous now when you think about it. >> their numbers actually are pretty good. guidance was pretty good. stock's getting whacked because -- coming back a little bit because the company come

seema mody to run through some of these names. seema?u take a look at what's behind me, you may think we're talking about the super bowl halftime show where madonna brought the house down. but that's not the case, we're looking at the halftime in america. if you look at the stocks in the s&p 500, 80% of stocks are up. i know what you're thinking, what about greece, the european debt crisis? our markets no doubt have had a volatile ride. but if we step back, these stocks are actually up, not just marginally. chipotle, wind resorts, coach, among others, these are consumer-driven stocks showing a lot of strength as we recover from the recession lows. up better than 500%. another interesting stat, thanks to the research team here at cnbc, 285 companies in the s&p are up more than 400% from their march 2009 low. but the question is, halfway through the recession, can we make our way out of it. and more importantly, do these stocks, we've seen monster moves, and can the momentum ride through going forward, and are these a good bet for the seco

seema mody, what about the technology side.retty much the hottest sector of all has been tech. >> that's right. technology just being this hot space to invest in. a couple of key levels to point out, the nasdaq is up around 56% since president obama got elected. in terms of 2012, the nasdaq is up better than 20% since the lows of 2011 when the markets turned for the worse. the reason for the recovery? we can thank upbeat corporate earnings from the likes of apple. the risk-on rally as investors put money to work in the new year. and semiconductor stocks have been a source of strength for the nasdaq. chip stocks have been rallying on the back of an improvement in the economy and recovery from these devastating thailand floods. that gives you an idea of why we've seen so much money flowing into tech in 2012. >> all right. seema and bob, thank you very much. now, let's bring in jim paulson, chief investment strategist at wells capital management and joins us now. jim, as always, you bring up excellent points. i want to hit the iss

seema mody will have more on this in a minute. decline there down 15%. profits at general mills missed estimates and they cut their full year guidance down $1.53. the stock right now at $38.25. nordstrom earnings, i've been there lately, got this suit there a few months ago. beat their estimates but the stock is down 2%. nonetheless, they warned on margins full year profit forecast was weaker than consensus. now you know where i shop. and for the latest action on the trading floors, let's go to courtney reagan from the nyse. courtney. >> hi, good afternoon, tyler. well, we're watching dow trying to get close to 13,000. we're about 68 points away right now. intel, one of those components in the dow, is moving nicely. take a look at it. we're seeing highs not seen since about december 27, 2007. so more than a four-year high here. the last time that intel was around these levels -- it was up rather i'm sorry 10% since the dow closed above 13,000. some good moves there. look what's going on in the oil services index. also near a six-month high as crude oil t

seema mody, rounding out the sector with the winners and losers. this is the place to be. >> stocks have been pretty mixed this afternoon as disappointing corporate news overshadowed the optimistic words from ben bernanke. we had a round of disappointing earnings from the pharmacies. that's why we're seeing weakness in health care today. merck with disappointing earnings today. we're waiting to hear from vertex pharmaceuticals. i'll get those earnings shortly after the bell. on the flip side, again, a lot of focus on technology. the nasdaq is up 10% year-to-date. today being helped by shares of qualcomm, reaching a 12-year high. and strong outlook for the rest of the year. switching focus to retail. retail has had a good run today as well. the biggest loser, though, on the s&p 500 today is abercrombie & fitch, down better than 13%. tumbling in trade to a 52-week low, after the company said their fourth-quarter results will not meet street estimates. that's due to weakness in u.s. sales. the retailer also expects margins to decline. two main reasons

i'm seema mody.the nasdaq continues to post gains, technology being one of the best performing sectors today. we've been speaking about apple as well as semiconductor stocks outperforming. chinese adrs, report earnings yesterday, they missed street estimates. on the conference call, the ceo saying their twitter light service will contribute to the top line on the second half of 2012. that's adding momentum to all of these stocks right now. money flying into international chinese stocks. nokia, downgraded by oppenheimer. >> seema, thank you very much. about 16 # minutes left in the trading session here, with the dow above 13,000 for the moment. let's check on the nasdaq. which is pushing its way to its highest close since december of 2000. it was up about 22 points at the hive of the day, up 19 right now. we're getting ever closer to the 3,000 mark on the nasdaq composite, now at 29 # 85. we talked earlier about volatility. the see sawing near break even right now, down just a fraction at 1802. it's b

i'm seema mody. another exciting day following tech here. not only are investors putting money into tech, but corporations paying hefty premiums in their respective industries. oracle buying taleo. aside from that, a slew of earnings to help the tech index. the fourth quarter profits topped wall street estimates. google is developing a home entertainment system. cumberland pharmaceuticals, u.s. regulators approved a patent for a new formulation of its liver drug. shares soaring in today's trade. >> thank you so much, seema. even as the u.s. continues to struggle with its own debt issues, the next guest, scott sperling, co-president of the thomas h.l. partners, his firm one of the oldest and experienced private equity firms. one of the nation's leading bayout fund organizations with more than $22 billion on management. it's good to see you again, scott. thank you so much for joining us. >> good to see you. >> let's talk about what's going on in america and why you are increasingly optimistic here. >> the united states is becoming increasingly

. >>> from the nasdaq market site, i'm seema mody. the norm in 2012, today getting a boost from economic data that came out this morning. take a note of the old school tech names, reaching historic highs. microsoft as mentioned before hit a four-year high this afternoon. dell has the tenth biggest impact on the nasdaq 100. cisco hitting a 52-week high. money definitely flowing into the big tech names. our biggest winner here on the nasdaq 100, that was net app posting strong gains after beating street expectations. >> seema, thank you so much. welcome back to the special edition of the "closing bell" coming to you live from the trading floor of second market. second market provides a trading platform for alternative investments like private companies. and fixed income instruments. the company recorded nearly $9 billion in trades last year. with more than 85,000 participants buying and selling these private companies. the biggest name traded on this platform, of course, has been facebook. it's about to go public. how does the second ma

i'm seema mody. another apple centric day. the nasdaq giving up its gains as shares of apple erased a 3% advance that continues to be a market driver. another stock to keep in mind, juniper networks, up better than 6.5%. some analysts say vendors like juniper should see a recover as carriers increase their spending. let's take a look at the biotech sector. amala norks is on the move. their new diabetes drug now available by prescription in the u.s. amylin shares up 2.5%. >> heading to the close. about 19 minutes left. as seema mentioned, nasdaq's been taking its cues from apple today, off the lows right now. but on pace for its third decline of the month. as apple falls off that lifetime high that we saw earlier in the session. right now, the nasdaq's down 15 points at 2,915. it was down 2,100 at the lows set just moments ago. in yellow flag territory, we're up two points, or 10%, well above that 20 level now. closing above 20 in the last four sessions here. mandy? >> okay, bill. well, oil prices are up over 3% this week. as i

i'm seema mody. let's check out some of the big movers.ping in trade after confirming promising data on their cancer drug. medivation helping the stock reach a three-month high. it's also heating up with the prostate drug on the market. they're moving higher because of a management change. the company is looking to increase patient volumes. guys, back over to you. >> seema, thank you very much. heading toward the close, 20 minutes left. time for a quick stat check on the nasdaq, which has been the leader today. the composite soaring to a six-month high. right now, a gain of 1.25%, or 34 points. it was up as many as 42 at the high of the session. technology has been the leader in this market once again. meanwhile, the fear indicator that the vix pulling back as stocks defy gravity. it's below 19 now, down almost 5%. off the lows of the session at 18.5 right now. maria? >> bill, let's take a look at aetna. profits jumping more than 70% in the fourth quarter. let's talk to aetna and how the company plans to stay ahead of the cur2012. joining

. >>> i'm seema mody. upbeat corporate earnings with the notable exception of amazon.com. seagate technologies, one of the wincers on the nasdaq 100. the management saying their customers are basically willing to pay more for the product because they want to avoid any risk of not getting enough supply of hard disk drives. the company's forecast alleviating concerns about seagate's business being damaged by the flooding in thailand. upgrading the stock from buy to hold. on the move, take a look at broadcom despite weakness in europe. the chipmaker beat the street with the quarterly numbers. the mobile computing number being the key driver there. qualcomm rising higher after hours. maria, back over to you. >> the "countdown" is on to facebook's ipo filing that could happen any now. julia, we hear you've got an exclusive sneak peek of the inner workings of facebook. tell us about it. >> i did, maria. it looked like a pretty boring corporate office here. but it's very cool inside. all exposed, you know, steel beams and unfinished wood and concrete floors. i hear that mark zuck

i'm seema mody. another strong day for the nasdaq. upbeat economic data driving the bulls into tech. let's start with one of our tech heavy weights, microsoft. definitely catching the attention of investors. hitting a four-year high in today's trade. another bright spot, some of those recently listed tech ipos showing strength. groupon and linkedin being said they're both overvalued. chip stocks, recovering lost ground after a softer than expected sales outlook for the year. some analysts i spoke to say this morning that the weak forecast, perhaps only a temporary setback. maria and bill? >> seema, thank you very much. we do have almost 18 minutes left in the trading session. time for a quick market stat check on the nasdaq. we're on pace to close at a mul multi-year high right now thanks to the strength in the technology sector. apple back above $500 after the big decline yesterday, which seemed to take the rest of the market with it. seema mentioned, microsoft has been stealing the show today, hitting that four-year high, above $31

. >>> i'm seema mody with your market wrap. the dow rises 46. it nears the 13,000 level.e nasdaq loses. consumer prices rose last month as gas and food costs were higher. camp bell's soup was up thanks to better than expected earnings. and yelp is slated to go public with 7 million shares priced between $12 and $14 a share. that's it from cnbc. now back to "hardball." >>> welcome back to "hardball." it looks like mitt romney is engaged in a high-risk strategy as he fights to win the first of his many home states. michigan, romney has taken every opportunity he can to start bashing the labor unions out there. here are a few of his recent jabs. let's watch him. >> i have taken on union bosses before. i'm happy to take them on again, because i happy to believe you can protect the interests and a great industry like automobiles without having to give in to the auw. >> some of the union bosses get things wrong. i'm concerned when i watch a president kowtow to the union bosses by putting in place the labor that stopped the boeing decision. >> let's make sure we have not crow kn

. >>> i'm seema mody. upbeat economic data, and news from apple sent the nasdaq up 19 points. it's a level that hasn't been reached since the year of 2000. on a run after the company sent invitations to the march 7th event in san francisco. it's expected to unveil the ipad3. other tech stocks on the move, microsoft, the second most heavily weight stock on the nasdaq, at one point the best performer on the s&p 500, ending in the green. some of the components of broad com ending higher on news of the ipad3. maria, back over to you. >> seema, thank you. priceline.com, shares continuing to soar in today's trading session. this on the heels of the better than expected fourth-quarter earnings released last night. revenue jumped at better than 40%. year over year increase of some 77%. oil and gas prices reach enough heights in the united states, can priceline keep this momentum going. joining me now is priceline.com president and ceo jeffery boyd. mr. boyd, thanks so much for your time today. good to have you on the program. >> thank you. >> earnings up 65% from a year ago. what's hi

. >>> i'm seema mody with your market wrap. the s&p adds three. the nasdaq gains three.mates. disney reported profits better than expected. but shares were off more than 1% off hours. a shakeup at yahoo has four board members announcing their departures. that's it from cnbc. now back to "hardball." >>> a romney nomination would not be in the best interest of us winning the general election. we need to have a conservative alternative. and my feeling is that speaker gingrich has had his chance in the arena and came up short in florida and nevada. and now it's our turn hopefully to get a one on one in missouri, which we have. >> welcome back to "hardball." that was rick santorum last night going after his republican rivals mitt romney and newt gingrich. there are three republican races today. minnesota, colorado, and missouri. santorum is trying to portray himself as the conservative alternative. the romney campaign has taken time to criticize santorum. so just what threat does santorum pose at this point? does he really have a chance to knock off romney? recently endorsed

i'm seema mody. another day, and another all-time high for apple.eports suggesting an ipad 3 launch in the first week of march, that's helping shares of apple today. also in the news, take a look at google. the doj is expected to give antitrust approval for the motorola mobility bid sometime early next week. oracle announcing the acquisition of aleo. it would give them a stronger foothold in the cloud computing space. that's certainly the trend in 2012. it's all about the cloud. also, take a look at yahoo!. that company making the headlines. "wall street journal" reporting that alibaba will buy back shares from yahoo!. maria and bill, over to you. >> seema, thank you very much. we are heading toward the close with about 35 minutes left in the day. we're watching technology. aren't we all. the nasdaq near that 11-year high, within 100 points of the 3,000 level now. so what's the best way to play it these days. let's start talking numbers. chris is here with us, head of technical analysis. what a juggernaut, the technology sector has been lately. >> i

i'm seema mody. let's resetd the markets for you. where'd the rally go?ook at our major indices, we're trading in negative territory. u.s. stocks, commodities selling off after bernanke dented hopes of a fresh round of monetary stimulus for the economy. another story i want to bring your attention to, the big story in the pharma world. the fda warning that patients taking cholesterol lowering stattens may face a slight increase in risk for diabetes and memory problems. now, stat ents the best selling class of drugs in history brought in an accumulative $130 billion in sales for pfizer alone in the last quarter. in q-4 they brought in $2 billion in sales. the big question is, will these pharma players be financially impacted? analysts i spoke to said they're not changing their ratings or estimates in response to this news. many of them already expect a deceleration in sales given the availability of generic options. it's still considered a headwind being monitored very closely. patients will naturally question if the benefits of being on a statten outweigh

seema mody is at that conference. >> reporter: for a while, investors, so focused on these major diseases, like heart disease and diabetes. of course there's a lot of opportunity there. as patents expire, fa ma players and investors are turning their attention to these rare diseases. there's a limited customer base. but you essentially own a piece of what could be a very lucrative market by having that first mover advantage. you can dictate pricing. we know pricing pressure has been a key challenge for a lot of pharma firms. they come on cnbc often and tell us that's one of the main things eating into their profit. a couple of hot bios is alexion. another one is biomarin. you guys will be chatting with the ceo. i was talking to j.j. a little while ago. he said there's a lot of untapped opportunity in the rare disease space. i'll let you guys take it from there. >> seema, thank you very much for the set-up there. biomarin pharmaceutical is one of the dominant players in this space. shares up nearly 42% over the past six months. what is the nothing know sis for rare disease treatments? let'

i'm seema mody. three stocks on our radar here. at micron tech, up better than 5.5%, expanding their joint venture with intel. the deal calls for micron to supply chips to intel. also on the move, take a look as shanghai listed sina corporation, their twitter service, weibo, will boost the second half. and priceline delivering an upbeat q1 guidance. the stock outperforming in today's trading session. >>> time is the biggest ally when it comes to retirement savings. if you're part of a growing population that needs to catch up, postponing your retirement by just three years may be the easiway to go. sharon epperson takes a deep dive on the ways to catch up. i'm listening, sharon. >> all right, sue. the h.r. consulting firm towers watson did a survey and found that 39% of workers plan to delay retirement. now, the findings in this survey mirrored what we found when we talked to a roundtable of financial experts. that is, for those delaying retirement, they plan to work an extra three years. >> if you have a job. i think part of this

seema mody wraps up the after-hours action. charles plosser is with me explaining why he believes the financial crisis for central banks blow the lines and create a moral hazard. he'll explain. stay with us. tdd# 1-800-345-2550 i'm constantly working my screens. tdd# 1-800-345-2550 checking the charts. tdd# 1-800-345-2550 looking for support, tdd# 1-800-345-2550 resistance, breakouts, tdd# 1-800-345-2550 a few other tricks that i'll keep to myself. tdd# 1-800-345-2550 that's how i trade. tdd# 1-800-345-2550 and i do it all with charles schwab, tdd# 1-800-345-2550 because their streetsmart edge platform tdd# 1-800-345-2550 helps me trade quickly, intuitively. tdd# 1-800-345-2550 staying on top of the market is key! tdd# 1-800-345-2550 and the momentum tool, tdd# 1-800-345-2550 it lets me do it at a glance, tdd# 1-800-345-2550 so when things shift, i'm ready. tdd# 1-800-345-2550 then to track the stocks i have my eye on, tdd# 1-800-345-2550 i turn to schwab's high/low ticker. tdd# 1-800-345-2550 so i can spot a potential breakout

i'm seema mody. the nasdaq up .3%. chip stocks continue to provide strength to the nasdaq.ese companies are seeing a recovery in demand and optimistic on seeing increase in corporate i.p. spending in 2012. take a look at the chart, a very clear spread. some of the movers in the semiconductor space, look at invidia, ending a patent dispute going back to 2008. the market always likes resolutions. bill? >> seema, thank you very much. we're heading to the close. about 19 minutes left here. time for a quick smarcheck on t nasdaq. a fresh 11-year high, on course for its sixth gain in the last seven sessions. up 9 points right now at 2913. it was down 11 at the day's lows around noontime eastern time today. volatility index has popped up, up 3% today. we're at 18 and change. unless it gets back to 20, you're not exactly seeing a yellow flag being waved. the last time it was above 20 was around january the 18th. maria, say hi to my friend warren. >> he's right here with me. tech up better than 11%. as far as the s&p technology index. warren myers with us. he's keeping an eye on the

. >>> i'm seema mody with your market wrap. the s&p is off half a point. the nasdaq is lower by 3.uilding. and boeing shares sank 1% after it said dream liners need repairs. that's it from cnbc first in business worldwide. now back to "hardball." >>> welcome back to "hardball." the economy is expected to be the main issue. there are several major flash points in the world that will affect the economy. they are in the middle east now. look at what the president is facing right now. just recent days, on syria, russia and china vetoed a resolution that would have called on assad to step down. the united states closed their embassy in demascas. they are on shaky ground after officials said 19 americans connected with the prodemocracy citizens. one is sam lahood. and most troubling, israeli leaders continuing to hint that military action by them is coming against iran. could that be an october surprise? the chief washington correspondent for "the new york times" joins us. david, let's go through the relatively easy. syria, why are we worried about so much? >> this has been a huge humani

let's check in with cnbc's seema mody. she joins us with the day's business headlines. >> hi, barbara. stocks opened higher, but pretty flat. news from europe continues to take its toll on our u.s. markets. greece's government said it was preparing an agreement on a $130 billion euro bailout that will be put to the nation's leaders later in the day. now, this delay in formulating a deal is keeping investors at edge, and thus the reason we're seeing some consolidation in our u.s. markets. nonetheless, though, u.s. majorin did he sees still up for the year. the nasdaq up 9% for year-to-date for 2012 and the dow up similarly, up 5%. in terms of stories we're following today, gasoline prices are hovering around a record high. in the month of january, retail gasoline prices averaged at $3.37 a gallon. this new record means more pain in american budgets. a typical household burning 50 gallons of gasoline a month paid $168 168.50 for that fuel in january or $33 more than in january of 2010. >>> in other news, federal reserve chai

seema mody's been following it. what can you tell us? >> another day and another recall for johnson & johnson. today recalling about a half million one-ounce bottles of infant tylenol after receiving complaints from parents that the container was difficult to use. guys, this isn't the first round of recalls. let's actually take a walk down history lane. we have composed a couple recalls that johnson & johnson has actually faced in 2012 as well as throughout 2011. so today this was the recall that was announced. in december though j & j recalled mote rin. two months before that recalls 200,000 syringes of its anemia drug. concerns there about poet ten si. in august removed about 2.5 million packages of tylenol cold multisymptom gel caps. and in june 2011 pulled 60,000 bottles of tylenol in the u.s. the reason there smelly odor. some compared to the lacquer put on wooden palettes. the rise in recalls poses several questions. is the fda approving drugs too quickly? is enough testing being done prior to being sold at the local pharma pharmac

i'm seema mody. time for three stocks in 30 seconds. let's start with novo, the world's largest insulin maker stock up 4%. moving onto merck, they also reported a profit of 97 cents a share, two cents higher than analyst projections. why is the stock down? guidance came shy of street expectations as they expect to lose sales to competitors once the number one drug goes off patent. and gilliad sciences, topic of conversation on the call will certainly be $11 billion acquisition of pharma asset and when they plan to launch the hepatitis c drug. >>> lawmakers holding hearings today on capitol hill about the collapse of mf global. this time they're focusing on the role of risk managers at the business. kayla tausche has the latest. >> simon, at this moment we have the reps from moody's and s&p testifying. they're in the thick of it. after this morning mf's former risk chiefs were grilled on the missing money. their answer they don't know and had nothing to do with that. but there was some familiar territory like whether mf global purposely

and seema mody is there rubbing shoulders with all the execs. >> it's kind of fitting that here on valentine's we're discussing all the matchmaking taking place in the biotech world. that's the chaugs at the bio ceo conference. large firms looking to bid out their pipeline via acquisitions and partnerships. more than $10 billion in m&a deals were announced during the first month of this year. bristol-myers inquiring inhibitex. amgen acquiring micromet, celgene taking out avila therapeutics. and as more put their cash to use, the more attention biotech is getting. interestingly enough, the big pops are coming from the smaller, under-the-radar firms. these have all moved sharply to the upside. investors i speak to say they have more room to run, and they're specifics lated bi biotargets that could be block busters. take a look at what the ceo told us on "squawk box." >> i think what you're seeing out there is an urgency to consolidate a lot of experimental medicines and get to that combination approach. >> now idenix continues to be a hot player in the hepatitis-c space. a lot of investors telli

. >>> moving to the pharma beat, we have seema mody talking jane j. recalls of iconic brand tylenol battered reputation and facing intense generic competition and stock gone nowhere over the past five years. can j & j's new ceo turn it around? talk about a long and winding road for them. >> it surely has been a winding road for the company. first priority for the company is to fix some of these glaring problems. they're dealing with manufacturing errors, ongoing supply chain issues and that all led to a series of recalls as you can see right here. now i've been speaking to analyst who is have covered this company since the news broke. overall a positive reaction to welden stepping down. and most thinking alex is up to the challenge. he's actually the 411 on the new face of j & j. he's a former army captain joined as a sales rep in '88. switched over in 2004 to head the north american pharmaceutical business and then returned to j & j. the question is will his top priority be? one can only speculate, but first it's pretty obvious no more recalls. fix t

seema mody is up now. she's joining us from the nasdaq -- or actually the realtime exchange.hind me. >> let's reset the markets. concerns over greece definitely weighing on our u.s. major indices. we have the dow witness triple digit losses. the s&p down 10 points. and the nasdaq down .7%. remember, it's been technology that's been the bright spot for this year and for the year currently down 21 points for the nasdaq. taking a look at our fear index, it's up right now 9.5%. the highest level year-to-date at 20. also seeing money flow out of commodities. take a look at oil trading at $98 a barrel. and gold also witnessing pressure. taking a look at some of our winners and losers on the s&p 500. take a look at shares of salesforce.com currently up 2% surging on a batch of analyst reports saying the company closed some significant deals. on the losing side, gamestop and first solar getting hammered. further project delays. and gamestop lowered by 4.5% sinking on weak sales data. and netapp down 4.4% ahead of earnings. look at movers and shakers. let's also look at gold and other

i'm seema mody. time for three stocks in 30 seconds.ith the most active stock here at the nasdaq. that's dendreon. roesh extended tender offer but did not raise its bid. aillumina replying back saying the offer does not reflect the unique leadership position. and vivus climbing telling the company fda approval by april 16th. tyler, back to you. >> a lot of drug stocks in the news. seema, thank you very much. looks like silence is golden. "the artist" coming up big, but moneyball struck out. does an oscar win translate into big money? here to talk about that and more is julia boorstin in los ange s angeles. i think of the best picture nominees only "the help" was over $100 million in the box office. is that going to propel the winners to make more money? >> tyler, the answer is yes. but not a huge amount more. in general winning an award and specifically best picture does generate higher returns at the box office and higher home video sales. on average the films that won best picture over a 10-year period brought home an average of their

i'm seema mody. time for three stocks in 30 seconds. starting with rambus. it's been in the news a lot, climbing higher after finding a resolution to one of those disputes signing a licensing agreement with the chipmaker. another stock to watch out for, akamai technologies. a company helps accelerate the speed of websites. lastly, brian mentioned this at the top but we're keeping a close eye on caesar's. our own kayla tausche will have more details coming up on "power lunch." for now, tyler, over to you. >> seema, thank you very much. the markets sort of struggling a little bit today. make no mistake, the dow is in rally mode recovering very nicely from the march 2009 lows up nearly 100% in that period of time, three years. in fact, all three major indexes charging to the upside over the past few months now in bull-market territory since october of last year, each up more than 20%. so much green on the board that blackrock's chief said today he thinks investors should be 100% in stocks. should investors be as bullish as mr. fink and go all in, or is there re